Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 2 |
NetGPI | no | yes: 0, no: 2 |
Related structures:
AlphaFold database: A4HMT3
Term | Name | Level | Count |
---|---|---|---|
GO:0001522 | pseudouridine synthesis | 6 | 3 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 3 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 3 |
GO:0006807 | nitrogen compound metabolic process | 2 | 3 |
GO:0008152 | metabolic process | 1 | 3 |
GO:0009451 | RNA modification | 5 | 3 |
GO:0009987 | cellular process | 1 | 3 |
GO:0016070 | RNA metabolic process | 5 | 3 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 3 |
GO:0043170 | macromolecule metabolic process | 3 | 3 |
GO:0043412 | macromolecule modification | 4 | 3 |
GO:0044237 | cellular metabolic process | 2 | 3 |
GO:0044238 | primary metabolic process | 2 | 3 |
GO:0046483 | heterocycle metabolic process | 3 | 3 |
GO:0071704 | organic substance metabolic process | 2 | 3 |
GO:0090304 | nucleic acid metabolic process | 4 | 3 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 3 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 3 |
GO:0003723 | RNA binding | 4 | 3 |
GO:0003824 | catalytic activity | 1 | 3 |
GO:0005488 | binding | 1 | 3 |
GO:0009982 | pseudouridine synthase activity | 4 | 3 |
GO:0016853 | isomerase activity | 2 | 3 |
GO:0016866 | intramolecular transferase activity | 3 | 3 |
GO:0097159 | organic cyclic compound binding | 2 | 3 |
GO:1901363 | heterocyclic compound binding | 2 | 3 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 206 | 210 | PF00656 | 0.386 |
CLV_NRD_NRD_1 | 15 | 17 | PF00675 | 0.371 |
CLV_NRD_NRD_1 | 172 | 174 | PF00675 | 0.363 |
CLV_NRD_NRD_1 | 287 | 289 | PF00675 | 0.398 |
CLV_NRD_NRD_1 | 305 | 307 | PF00675 | 0.511 |
CLV_NRD_NRD_1 | 57 | 59 | PF00675 | 0.316 |
CLV_PCSK_KEX2_1 | 15 | 17 | PF00082 | 0.371 |
CLV_PCSK_KEX2_1 | 172 | 174 | PF00082 | 0.331 |
CLV_PCSK_KEX2_1 | 253 | 255 | PF00082 | 0.601 |
CLV_PCSK_KEX2_1 | 287 | 289 | PF00082 | 0.398 |
CLV_PCSK_KEX2_1 | 305 | 307 | PF00082 | 0.495 |
CLV_PCSK_KEX2_1 | 57 | 59 | PF00082 | 0.316 |
CLV_PCSK_PC1ET2_1 | 253 | 255 | PF00082 | 0.346 |
CLV_PCSK_SKI1_1 | 173 | 177 | PF00082 | 0.317 |
CLV_PCSK_SKI1_1 | 232 | 236 | PF00082 | 0.323 |
CLV_PCSK_SKI1_1 | 305 | 309 | PF00082 | 0.351 |
CLV_PCSK_SKI1_1 | 336 | 340 | PF00082 | 0.343 |
CLV_PCSK_SKI1_1 | 351 | 355 | PF00082 | 0.405 |
DEG_ODPH_VHL_1 | 229 | 241 | PF01847 | 0.292 |
DOC_CYCLIN_RxL_1 | 74 | 84 | PF00134 | 0.318 |
DOC_MAPK_DCC_7 | 74 | 82 | PF00069 | 0.324 |
DOC_MAPK_gen_1 | 101 | 111 | PF00069 | 0.525 |
DOC_MAPK_MEF2A_6 | 232 | 241 | PF00069 | 0.292 |
DOC_PP1_SILK_1 | 276 | 281 | PF00149 | 0.318 |
DOC_PP2B_LxvP_1 | 239 | 242 | PF13499 | 0.307 |
DOC_PP4_FxxP_1 | 308 | 311 | PF00568 | 0.351 |
DOC_PP4_FxxP_1 | 323 | 326 | PF00568 | 0.322 |
DOC_USP7_MATH_1 | 11 | 15 | PF00917 | 0.364 |
DOC_USP7_MATH_1 | 127 | 131 | PF00917 | 0.391 |
DOC_USP7_MATH_1 | 201 | 205 | PF00917 | 0.369 |
DOC_USP7_MATH_1 | 326 | 330 | PF00917 | 0.396 |
DOC_USP7_MATH_1 | 96 | 100 | PF00917 | 0.286 |
DOC_USP7_UBL2_3 | 310 | 314 | PF12436 | 0.362 |
DOC_WW_Pin1_4 | 280 | 285 | PF00397 | 0.406 |
DOC_WW_Pin1_4 | 342 | 347 | PF00397 | 0.393 |
DOC_WW_Pin1_4 | 7 | 12 | PF00397 | 0.367 |
LIG_14-3-3_CanoR_1 | 184 | 191 | PF00244 | 0.271 |
LIG_14-3-3_CterR_2 | 356 | 358 | PF00244 | 0.443 |
LIG_APCC_ABBAyCdc20_2 | 268 | 274 | PF00400 | 0.294 |
LIG_BRCT_BRCA1_1 | 346 | 350 | PF00533 | 0.390 |
LIG_FHA_1 | 184 | 190 | PF00498 | 0.276 |
LIG_FHA_1 | 330 | 336 | PF00498 | 0.374 |
LIG_FHA_2 | 174 | 180 | PF00498 | 0.295 |
LIG_LIR_Gen_1 | 153 | 162 | PF02991 | 0.356 |
LIG_LIR_Gen_1 | 209 | 219 | PF02991 | 0.307 |
LIG_LIR_Gen_1 | 91 | 100 | PF02991 | 0.524 |
LIG_LIR_Nem_3 | 153 | 157 | PF02991 | 0.349 |
LIG_LIR_Nem_3 | 168 | 174 | PF02991 | 0.335 |
LIG_LIR_Nem_3 | 209 | 215 | PF02991 | 0.371 |
LIG_LIR_Nem_3 | 246 | 250 | PF02991 | 0.336 |
LIG_LIR_Nem_3 | 347 | 353 | PF02991 | 0.663 |
LIG_LIR_Nem_3 | 91 | 97 | PF02991 | 0.520 |
LIG_PCNA_yPIPBox_3 | 177 | 189 | PF02747 | 0.292 |
LIG_REV1ctd_RIR_1 | 305 | 310 | PF16727 | 0.354 |
LIG_SH2_CRK | 171 | 175 | PF00017 | 0.315 |
LIG_SH2_CRK | 281 | 285 | PF00017 | 0.369 |
LIG_SH2_STAP1 | 31 | 35 | PF00017 | 0.371 |
LIG_SH2_STAT3 | 272 | 275 | PF00017 | 0.310 |
LIG_SH2_STAT3 | 31 | 34 | PF00017 | 0.368 |
LIG_SH2_STAT5 | 248 | 251 | PF00017 | 0.258 |
LIG_SH3_3 | 185 | 191 | PF00018 | 0.359 |
LIG_SH3_3 | 41 | 47 | PF00018 | 0.391 |
LIG_SH3_4 | 310 | 317 | PF00018 | 0.356 |
LIG_SUMO_SIM_par_1 | 78 | 84 | PF11976 | 0.312 |
LIG_TRAF2_1 | 150 | 153 | PF00917 | 0.379 |
LIG_TRFH_1 | 307 | 311 | PF08558 | 0.355 |
LIG_UBA3_1 | 211 | 217 | PF00899 | 0.352 |
LIG_WRC_WIRS_1 | 190 | 195 | PF05994 | 0.263 |
MOD_CDK_SPK_2 | 7 | 12 | PF00069 | 0.367 |
MOD_CDK_SPxxK_3 | 280 | 287 | PF00069 | 0.361 |
MOD_CK1_1 | 10 | 16 | PF00069 | 0.365 |
MOD_CK1_1 | 155 | 161 | PF00069 | 0.372 |
MOD_CK1_1 | 283 | 289 | PF00069 | 0.418 |
MOD_CK1_1 | 329 | 335 | PF00069 | 0.321 |
MOD_CK2_1 | 173 | 179 | PF00069 | 0.361 |
MOD_GlcNHglycan | 129 | 132 | PF01048 | 0.382 |
MOD_GlcNHglycan | 148 | 151 | PF01048 | 0.338 |
MOD_GlcNHglycan | 153 | 157 | PF01048 | 0.342 |
MOD_GlcNHglycan | 17 | 21 | PF01048 | 0.329 |
MOD_GlcNHglycan | 332 | 335 | PF01048 | 0.362 |
MOD_GlcNHglycan | 346 | 349 | PF01048 | 0.387 |
MOD_GlcNHglycan | 68 | 71 | PF01048 | 0.363 |
MOD_GSK3_1 | 326 | 333 | PF00069 | 0.352 |
MOD_GSK3_1 | 340 | 347 | PF00069 | 0.520 |
MOD_GSK3_1 | 351 | 358 | PF00069 | 0.419 |
MOD_GSK3_1 | 7 | 14 | PF00069 | 0.357 |
MOD_N-GLC_1 | 243 | 248 | PF02516 | 0.296 |
MOD_NEK2_1 | 146 | 151 | PF00069 | 0.507 |
MOD_NEK2_1 | 211 | 216 | PF00069 | 0.292 |
MOD_NEK2_1 | 267 | 272 | PF00069 | 0.286 |
MOD_NEK2_1 | 315 | 320 | PF00069 | 0.358 |
MOD_NEK2_1 | 321 | 326 | PF00069 | 0.340 |
MOD_NEK2_1 | 340 | 345 | PF00069 | 0.384 |
MOD_NEK2_2 | 96 | 101 | PF00069 | 0.283 |
MOD_PIKK_1 | 119 | 125 | PF00454 | 0.419 |
MOD_PKA_2 | 11 | 17 | PF00069 | 0.366 |
MOD_PKA_2 | 183 | 189 | PF00069 | 0.271 |
MOD_PKA_2 | 286 | 292 | PF00069 | 0.389 |
MOD_PKA_2 | 39 | 45 | PF00069 | 0.399 |
MOD_Plk_1 | 152 | 158 | PF00069 | 0.379 |
MOD_Plk_1 | 243 | 249 | PF00069 | 0.284 |
MOD_Plk_4 | 243 | 249 | PF00069 | 0.293 |
MOD_Plk_4 | 267 | 273 | PF00069 | 0.291 |
MOD_ProDKin_1 | 280 | 286 | PF00069 | 0.402 |
MOD_ProDKin_1 | 342 | 348 | PF00069 | 0.389 |
MOD_ProDKin_1 | 7 | 13 | PF00069 | 0.358 |
TRG_AP2beta_CARGO_1 | 91 | 101 | PF09066 | 0.282 |
TRG_DiLeu_BaLyEn_6 | 234 | 239 | PF01217 | 0.285 |
TRG_DiLeu_BaLyEn_6 | 348 | 353 | PF01217 | 0.395 |
TRG_ENDOCYTIC_2 | 171 | 174 | PF00928 | 0.308 |
TRG_ER_diArg_1 | 171 | 173 | PF00400 | 0.351 |
TRG_ER_diArg_1 | 305 | 307 | PF00400 | 0.595 |
TRG_ER_diArg_1 | 56 | 58 | PF00400 | 0.314 |
TRG_NES_CRM1_1 | 209 | 222 | PF08389 | 0.307 |
TRG_Pf-PMV_PEXEL_1 | 236 | 240 | PF00026 | 0.290 |
TRG_Pf-PMV_PEXEL_1 | 78 | 83 | PF00026 | 0.314 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
V5BD35 | Trypanosoma cruzi | 41% | 100% |